Paper17560328
A CERTain role for ceramide in taxane-induced cell death.
Kolesnick R and 2 others. Cancer Cell, 2007. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. A CERTain role for ceramide in taxane-induced cell death. Papers, record 17560328. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17560328
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Death | Major topic |
| Ceramides | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Paclitaxel | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Bridged-Ring Compounds | |
| Chromosomal Instability | |
| Humans | |
| Mitosis | |
| Polyploidy | |
| Protein Folding | |
| RNA, Small Interfering | |
| Spindle Apparatus | |
| Taxoids | |
| Tumor Cells, Cultured |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 17560332 | Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. | https://conductscience.org/library/papers/17560332 |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41644096 | An integrative approach to studying sphingolipid metabolism reveals p53 as a master regulator of the pathway. | J Lipid Res | 2026 | https://conductscience.org/library/papers/41644096 | PubMed |
| 39125841 | Sphingosine 1-Phosphate Stimulates ER to Golgi Ceramide Traffic to Promote Survival in T98G Glioma Cells. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39125841 | PubMed |
| 33429049 | Sphingolipids in embryonic development, cell cycle regulation, and stemness - Implications for polyploidy in tumors. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/33429049 | PubMed |
| 32211323 | Metabolic Plasticity in Chemotherapy Resistance. | Front Oncol | 2020 | https://conductscience.org/library/papers/32211323 | PubMed |
| 31891125 | Sphingolipid metabolism and drug resistance in ovarian cancer. | Cancer Drug Resist | 2018 | https://conductscience.org/library/papers/31891125 | PubMed |
| 31861664 | Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31861664 | PubMed |
| 29731990 | Ceramide species are elevated in human breast cancer and are associated with less aggressiveness. | Oncotarget | 2018 | https://conductscience.org/library/papers/29731990 | PubMed |
| 28592871 | Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo. | Sci Rep | 2017 | https://conductscience.org/library/papers/28592871 | PubMed |
| 23833655 | Paclitaxel disrupts polarized entry of membrane-permeable C6 ceramide into ovarian cancer cells resulting in synchronous induction of cell death. | Oncol Lett | 2013 | https://conductscience.org/library/papers/23833655 | PubMed |
| 23235911 | Ceramide-orchestrated signalling in cancer cells. | Nat Rev Cancer | 2013 | https://conductscience.org/library/papers/23235911 | PubMed |
| 22052905 | Autophagy induced by deficiency of sphingosine-1-phosphate phosphohydrolase 1 is switched to apoptosis by calpain-mediated autophagy-related gene 5 (Atg5) cleavage. | J Biol Chem | 2011 | https://conductscience.org/library/papers/22052905 | PubMed |
| 21617856 | Glucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in metastatic breast carcinoma. | Int J Oncol | 2011 | https://conductscience.org/library/papers/21617856 | PubMed |
| 21490804 | Apoptotic sphingolipid ceramide in cancer therapy. | J Lipids | 2011 | https://conductscience.org/library/papers/21490804 | PubMed |
| 20540746 | Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling. | Mol Cancer | 2010 | https://conductscience.org/library/papers/20540746 | PubMed |
| 19826105 | Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase. | J Lipid Res | 2010 | https://conductscience.org/library/papers/19826105 | PubMed |
| 19742320 | A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis. | PLoS One | 2009 | https://conductscience.org/library/papers/19742320 | PubMed |
| 19425170 | Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. | J Clin Invest | 2009 | https://conductscience.org/library/papers/19425170 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CERT1 | 10087 | PubTator's text mining | https://conductscience.org/library/genes/10087 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17560328
GET https://conductscience.org/api/papers/v1/17560328/authors